Yin Hongjun, Wang Shengfeng, Qu Jiuxin, Zhou Fei, Wang Chen, Cao Bin
Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.
National Clinical Research Center for Respiratory Disease, Beijing, China.
Clin Respir J. 2020 Oct;14(10):933-939. doi: 10.1111/crj.13224. Epub 2020 Jul 21.
The long-term mortality rate in adolescent and middle-aged patients with low-medium risk community-acquired pneumonia (CAP) remains unelucidated.
Understanding the long-term mortality rate in adolescent and middle-aged patients with low-medium risk CAP in Beijing, China, to provide a basis for the long-term management of CAP patient.
A follow-up survey was conducted telephonically from December 2017 to January 2018 to assess the survival status among 808 patients from a CAP-China cohort enrolled from 10 general hospitals in Beijing between November 2010 and April 2012. The all-cause mortality rate was determined and Cox's proportional hazard model was performed to identify potential factors predicting mortality.
Among the 808 patients, the mean age (SD) was 45.4 (19.6) year-old and the median (IQR) pneumonia severity index (PSI) score was 42.0 (35.8). Survival status for a total of 426 (52.7%) were determined during the follow-up and the non-follow-up patients were with slightly larger PSI score. The mean age (SD) for the follow-up patients were 44.6 (18.7) year-old and the median (IQR) PSI score was 42.0 (33.3). Over a median of 7 years, 32 participants died and the cumulative 1-, 3-, 5- and 7-year all-cause mortality rates were 1.6%, 4.2%, 5.9% and 7.5%, respectively. The average annual standardized mortality rate among the study participants was 9.79‰, which was significantly higher than the mortality rate of 5.20‰ among Beijing residents in 2016. Multivariable Cox proportional hazards analyses revealed that age, comorbidity and PSI were independent prognostic factors associated with long-term mortality, with hazard ratios of 4.953 (95% confidence interval [CI]3.270-7.502), 2.393 (95% CI 1.148-4.985) and 3.553 (95% CI 2.607-4.843), respectively. [Correction added on 20 August 2020, after first online publication: "9.79%" has been corrected to "9.79‰".] CONCLUSION: The long-term mortality rate is higher among patients with CAP compared with the age-adjusted general population in the same city. Age, comorbidity and initial PSI class are independently prognostic factors for the long-term mortality rate.
青少年和中年低中风险社区获得性肺炎(CAP)患者的长期死亡率仍不明确。
了解中国北京青少年和中年低中风险CAP患者的长期死亡率,为CAP患者的长期管理提供依据。
2017年12月至2018年1月进行了电话随访调查,以评估2010年11月至2012年4月期间从北京10家综合医院纳入的CAP-China队列中808例患者的生存状况。确定全因死亡率,并进行Cox比例风险模型分析以识别预测死亡率的潜在因素。
808例患者中,平均年龄(标准差)为45.4(19.6)岁,肺炎严重程度指数(PSI)评分中位数(四分位间距)为42.0(35.8)。随访期间共确定了426例(52.7%)患者的生存状况,未随访患者的PSI评分略高。随访患者的平均年龄(标准差)为44.6(18.7)岁,PSI评分中位数(四分位间距)为42.0(33.3)。在中位7年的时间里,32名参与者死亡,累积1年、3年、5年和7年的全因死亡率分别为1.6%、4.2%、5.9%和7.5%。研究参与者的年均标准化死亡率为9.79‰,显著高于2016年北京居民5.20‰的死亡率。多变量Cox比例风险分析显示,年龄、合并症和PSI是与长期死亡率相关的独立预后因素,风险比分别为4.953(95%置信区间[CI]3.270-7.502)、2.393(95%CI 1.148-4.985)和3.553(95%CI 2.607-4.843)。[2020年8月20日首次在线发表后更正:“9.79%”已更正为“9.79‰”。]结论:与同城市年龄调整后的普通人群相比,CAP患者的长期死亡率更高。年龄、合并症和初始PSI分级是长期死亡率的独立预后因素。